
Circumvent
Utilizing monogenic disorders to inform and solve highly complex…
- Location
- Portland, OR, United States
- Team size
- 6 employees
- YC batch
- Summer 2018
- Status
- Active
- Stage
- Early stage

Utilizing monogenic disorders to inform and solve highly complex…

What they do:
AI drug discovery platform for neurotherapeutics
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$2.16M · Options · Feb 2026

What they do:
Next-generation mRNA platform to solve cancer, COVID and climate.
Quick facts:
HQ: Boston, MA, United States

What they do:
Patient Intelligence Platform for Genetic Disease
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Arpeggio Bio develops drugs targeting transcription factors using AI…
Quick facts:
HQ: Boulder, CO, United States

What they do:
Kernal is creating mRNA 2.0 therapies that work in specific cells
Quick facts:
HQ: Boston, MA, United States

What they do:
Discovering drugs that target the DNA regulome
Quick facts:
HQ: Seattle, WA, United States
Utilizing monogenic disorders to inform and solve highly complex…
Portland, OR, United States
6 employees, according to the company profile.
There are no funding rounds for Circumvent in our data.
Similar startups: Exin Therapeutics, Helix Nanotechnologies, and Probably Genetic.